Financial results - PHARMICS SRL

Financial Summary - Pharmics Srl
Unique identification code: 23200539
Registration number: J2008000441126
Nace: 4646
Sales - Ron
13.368.623
Net Profit - Ron
2.683.878
Employees
18
Open Account
Company Pharmics Srl with Fiscal Code 23200539 recorded a turnover of 2024 of 13.368.623, with a net profit of 2.683.878 and having an average number of employees of 18. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmics Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 3.293.109 4.095.294 3.711.684 3.293.427 7.353.878 6.203.915 7.142.597 11.299.580 12.658.027 13.368.623
Total Income - EUR 3.479.986 4.182.601 3.861.257 3.314.203 7.452.948 6.257.077 7.242.858 11.898.973 13.549.429 13.613.921
Total Expenses - EUR 2.353.283 2.865.342 2.760.984 2.373.555 4.867.577 4.312.042 5.331.760 9.249.752 10.051.698 10.507.416
Gross Profit/Loss - EUR 1.126.703 1.317.260 1.100.273 940.648 2.585.371 1.945.035 1.911.098 2.649.221 3.497.731 3.106.505
Net Profit/Loss - EUR 954.310 1.115.340 924.668 781.313 2.165.708 1.640.560 1.610.952 2.238.798 2.934.421 2.683.878
Employees 10 13 12 14 15 15 14 15 15 18
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 6.2%, from 12.658.027 euro in the year 2023, to 13.368.623 euro in 2024. The Net Profit decreased by -234.144 euro, from 2.934.421 euro in 2023, to 2.683.878 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmics Srl

Rating financiar

Financial Rating -
PHARMICS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmics Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmics Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmics Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmics Srl - CUI 23200539

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 1.740.094 1.951.983 1.877.551 1.733.794 1.620.178 1.570.680 2.118.485 2.945.852 4.267.212 4.556.587
Current Assets 2.702.282 2.747.448 2.508.881 2.609.122 4.180.086 4.493.228 5.029.551 8.279.406 9.305.942 9.282.956
Inventories 344.318 396.603 497.102 721.096 1.262.395 1.184.193 1.177.803 1.335.772 1.139.830 1.675.000
Receivables 763.879 601.226 660.863 792.092 1.159.601 2.075.771 2.840.722 4.455.268 4.972.474 5.899.730
Cash 1.594.085 1.749.618 1.350.916 1.095.934 1.758.091 1.233.263 1.011.026 2.488.366 3.193.638 1.708.225
Shareholders Funds 3.158.919 3.005.596 3.139.720 3.359.718 4.537.335 4.523.951 5.105.324 3.986.001 6.908.335 8.090.282
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 1.291.897 1.700.612 1.248.542 987.887 1.267.842 1.548.505 2.053.292 7.247.518 6.671.511 5.754.874
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 9.282.956 euro in 2024 which includes Inventories of 1.675.000 euro, Receivables of 5.899.730 euro and cash availability of 1.708.225 euro.
The company's Equity was valued at 8.090.282 euro, while total Liabilities amounted to 5.754.874 euro. Equity increased by 1.220.555 euro, from 6.908.335 euro in 2023, to 8.090.282 in 2024.

Risk Reports Prices

Reviews - Pharmics Srl

Comments - Pharmics Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.